Lipid and fatty acid composition is altered in plaque tissue from multiple sclerosis brain compared with normal brain

R Wilson1, D R Tocher

  • 1Department of Biological and Molecular Sciences, School of Natural Sciences, University of Stirling, Scotland, U.K.

Lipids
|January 1, 1991
PubMed

Insights

Multiple sclerosis (MS) brain plaques show altered lipid profiles, with reduced total lipid and changes in fatty acid composition. These findings offer insights into the biochemical changes in MS lesions.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pathology

Background:

  • Multiple sclerosis (MS) is a chronic inflammatory disease affecting the central nervous system.
  • Lipid alterations are implicated in the pathogenesis of MS, but detailed analysis of plaque composition is ongoing.

Purpose of the Study:

  • To comprehensively analyze the lipid content, class, and fatty acid composition in MS plaques.
  • To compare these lipid profiles with normal white matter to identify disease-specific changes.

Main Methods:

  • Analysis of lipid content, class composition, and fatty acid profiles in brain plaques and white matter from MS patients and normal controls.
  • Specific examination of glycerophospholipid fatty acid composition within MS plaques.

Main Results:

  • MS plaques contained significantly less total lipid (<30%) compared to normal white matter.
  • Plaque lipid showed increased glycerophospholipids and decreased cerebrosides/sulfatides.
  • Increased saturated and polyunsaturated fatty acids, with decreased monoenes, were observed in total plaque lipid.
  • Subacute plaques had markedly higher steryl ester content than chronic plaques or normal tissue.
  • Fatty acid changes in plaque glycerophospholipids were distinct from overall lipid alterations, indicating specific molecular modifications.

Conclusions:

  • MS plaques exhibit profound alterations in lipid composition and fatty acid profiles.
  • These changes suggest increased cellularity and astrogliosis, but also point to intrinsic alterations in glycerophospholipid metabolism within plaques.
  • Further research into these specific lipid changes may reveal novel therapeutic targets for multiple sclerosis.

Related Concept Videos

Inflammation01:38

Inflammation

Overview
46.6K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
20
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
35